Serving leading biopharmaceutical companies globally:

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

EPOGEN/PROCRIT Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: EPOGEN/PROCRIT

Patents:	81
Applicants:	1
BLAs:	1
Suppliers: see list	2
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EPOGEN/PROCRIT

Pharmacology for EPOGEN/PROCRIT

Ingredient-type	Erythropoietin
Physiological Effect	Increased Erythroid Cell Production

US Patents for EPOGEN/PROCRIT

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	Bayer Intellectual Property GMBH (Monheim, DE)	2026-12-05	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	BIOSUCCESS BIOTECH COMPANY (Los Angeles, CA)	2027-01-31	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	Bayer Pharma Aktiengesellshaft (Berlin, DE)	2032-08-16	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY)	2034-12-23	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	YALE UNIVERSITY (New Haven, CT)	2032-04-26	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing		2030-02-02	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	007	1989-06-01	See Pricing	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for EPOGEN/PROCRIT

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Estimated Expiration
Australia	5705398	See Pricing
South Korea	20040011458	See Pricing
Russian Federation	2017136530	See Pricing
South Korea	20140051378	See Pricing
Israel	186254	See Pricing
Japan	5577354	See Pricing
Canada	2966451	See Pricing
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Express Scripts

Boehringer Ingelheim

Johnson and Johnson

Moodys

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.